A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma

Figure 7

Enrichment analysis of NCG-related model. (a) KEGG pathway enrichment analysis based on the risk score of NCG-related model. (b) HALLMARKER enrichment analysis based on the risk score of NCG-related model. (c) Correlation analysis between NCGs and KEGG enrichment pathway. (d) Correlation analysis between NCGs and Hallmark enrichment pathway.

(a)

(b)

(c)

(d)